Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

The timing of sulfadiazine therapy impacts the reactivation of latent Toxoplasma infection in IRF-8-/- mice.

Jost C, Reiter-Owona I, Liesenfeld O.

Parasitol Res. 2007 Nov;101(6):1603-9. Epub 2007 Sep 12.

PMID:
17846793
2.

A clinical-parasitological monotherapy cure in the treatment of experimental infection by a highly virulent strain of Toxoplasma gondii.

de Diego JA, Penin P, Arribas JR, Vázquez E, Vázquez JJ.

Folia Microbiol (Praha). 1996;41(6):513-6.

PMID:
9131805
3.

Detection of the initial site of Toxoplasma gondii reactivation in brain tissue.

Takashima Y, Suzuki K, Xuan X, Nishikawa Y, Unno A, Kitoh K.

Int J Parasitol. 2008 Apr;38(5):601-7. Epub 2007 Oct 14.

PMID:
18022177
4.

Stage conversion of Toxoplasma gondii RH parasites in mice by treatment with atovaquone and pyrrolidine dithiocarbamate.

Djurković-Djaković O, Nikolić A, Bobić B, Klun I, Aleksić A.

Microbes Infect. 2005 Jan;7(1):49-54. Epub 2004 Dec 15.

PMID:
15716077
5.

Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis.

Dunay IR, Heimesaat MM, Bushrab FN, Müller RH, Stocker H, Arasteh K, Kurowski M, Fitzner R, Borner K, Liesenfeld O.

Antimicrob Agents Chemother. 2004 Dec;48(12):4848-54.

6.

Toxoplasma gondii: determination of the onset of chronic infection in mice and the in vitro reactivation of brain cysts.

Chew WK, Wah MJ, Ambu S, Segarra I.

Exp Parasitol. 2012 Jan;130(1):22-5. doi: 10.1016/j.exppara.2011.10.004. Epub 2011 Oct 18.

PMID:
22027550
8.

Recombinant bactericidal/permeability-increasing protein (rBPI21) in combination with sulfadiazine is active against Toxoplasma gondii.

Khan AA, Lambert LH Jr, Remington JS, Araujo FG.

Antimicrob Agents Chemother. 1999 Apr;43(4):758-62.

9.

Rifabutin is active in murine models of toxoplasmosis.

Araujo FG, Slifer T, Remington JS.

Antimicrob Agents Chemother. 1994 Mar;38(3):570-5.

10.

Toxoplasma gondii antigens recognized by IgG antibodies differ between mice with and without active proliferation of tachyzoites in the brain during the chronic stage of infection.

Hester J, Mullins J, Sa Q, Payne L, Mercier C, Cesbron-Delauw MF, Suzuki Y.

Infect Immun. 2012 Oct;80(10):3611-20. doi: 10.1128/IAI.00604-12. Epub 2012 Jul 30.

12.

Real-time RT-PCR on SAG1 and BAG1 gene expression during stage conversion in immunosuppressed mice infected with Toxoplasma gondii Tehran strain.

Selseleh M, Modarressi MH, Mohebali M, Shojaee S, Eshragian MR, Selseleh M, Azizi E, Keshavarz H.

Korean J Parasitol. 2012 Sep;50(3):199-205. doi: 10.3347/kjp.2012.50.3.199. Epub 2012 Aug 13.

14.
16.

Toxoplasma gondii: in vitro and in vivo activities of the hydroxynaphthoquinone 2-hydroxy-3-(1'-propen-3-phenyl)-1,4-naphthoquinone alone or combined with sulfadiazine.

Ferreira RA, Oliveira AB, Ribeiro MF, Tafuri WL, Vitor RW.

Exp Parasitol. 2006 Jun;113(2):125-9. Epub 2006 Feb 3.

PMID:
16458300
17.

Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model.

Martins-Duarte ÉS, de Souza W, Vommaro RC.

Exp Parasitol. 2013 Mar;133(3):294-9. doi: 10.1016/j.exppara.2012.12.011. Epub 2012 Dec 25.

18.

VCAM-1/α4β1 integrin interaction is crucial for prompt recruitment of immune T cells into the brain during the early stage of reactivation of chronic infection with Toxoplasma gondii to prevent toxoplasmic encephalitis.

Sa Q, Ochiai E, Sengoku T, Wilson ME, Brogli M, Crutcher S, Michie SA, Xu B, Payne L, Wang X, Suzuki Y.

Infect Immun. 2014 Jul;82(7):2826-39. doi: 10.1128/IAI.01494-13. Epub 2014 Apr 21.

20.

SDS-coated atovaquone nanosuspensions show improved therapeutic efficacy against experimental acquired and reactivated toxoplasmosis by improving passage of gastrointestinal and blood-brain barriers.

Shubar HM, Lachenmaier S, Heimesaat MM, Lohman U, Mauludin R, Mueller RH, Fitzner R, Borner K, Liesenfeld O.

J Drug Target. 2011 Feb;19(2):114-24. doi: 10.3109/10611861003733995. Epub 2010 Apr 1.

PMID:
20367080

Supplemental Content

Support Center